Tubastatin A: HDAC6 Inhibition Beyond Oncology—Mechanisms...
2026-01-19
Explore how Tubastatin A, a selective HDAC6 inhibitor, is redefining therapeutic strategies not only in cancer biology but also in inflammation, neuroprotection, and myocardial injury. Discover unique mechanistic insights and translational advances that set this analysis apart.